Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

468 Ozarelix
564899b463fcb9442e46a6d9fa16f10be8a633b23d52d99f31b340a32e1280db

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Ozarelix (developmental code names D-63153, SPI-153) is a peptide gonadotropin-releasing hormone antagonist (GnRH antagonist) which is or was under development by AEterna Zentaris Inc. and Spectrum Pharmaceuticals as a long-acting injection formulation for the treatment of prostate cancer. It has also been investigated for the treatment of endometriosis, but no development has been reported. The drug was previously under investigation for the treatment of benign prostatic hyperplasia and Alzheimer's disease as well, but development for these indications was discontinued. As of June 2015, it was in phase II clinical trials for prostate cancer. It seems to no longer be under development.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
467 Next ≫
469
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan